Literature DB >> 15069952

Hsp90 isoforms: functions, expression and clinical importance.

Amere Subbarao Sreedhar1, Eva Kalmár, Péter Csermely, Yu-Fei Shen.   

Abstract

The 90 kDa heat shock protein, Hsp90, is a main functional component of an important cytoplasmic chaperone complex, and it is involved in various cellular processes, such as cell proliferation, differentiation and apoptosis. Identification of Hsp90 as a molecular target of various anticancer drugs highlighted its importance from the clinical point of view. Here we summarize the current knowledge of various Hsp90 isoforms regarding their genomic location, molecular evolution, functional differences, differential induction after various environmental stresses and in pathological conditions as well as the growing importance of discriminating between Hsp90 isoforms in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15069952     DOI: 10.1016/s0014-5793(04)00229-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  191 in total

1.  The expanding proteome of the molecular chaperone HSP90.

Authors:  Rahul S Samant; Paul A Clarke; Paul Workman
Journal:  Cell Cycle       Date:  2012-04-01       Impact factor: 4.534

2.  Novel C-terminal Hsp90 inhibitor for head and neck squamous cell cancer (HNSCC) with in vivo efficacy and improved toxicity profiles compared with standard agents.

Authors:  Stephanie M Cohen; Ridhwi Mukerji; Abbas K Samadi; Xuan Zhang; Huiping Zhao; Brian S J Blagg; Mark S Cohen
Journal:  Ann Surg Oncol       Date:  2011-08-12       Impact factor: 5.344

3.  Development of a Grp94 inhibitor.

Authors:  Adam S Duerfeldt; Laura B Peterson; Jason C Maynard; Chun Leung Ng; Davide Eletto; Olga Ostrovsky; Heather E Shinogle; David S Moore; Yair Argon; Christopher V Nicchitta; Brian S J Blagg
Journal:  J Am Chem Soc       Date:  2012-05-29       Impact factor: 15.419

4.  In silico analysis of regulatory and structural motifs of the ovine HSP90AA1 gene.

Authors:  Carmen González; Judit Salces-Ortiz; Jorge H Calvo; M Magdalena Serrano
Journal:  Cell Stress Chaperones       Date:  2016-01-26       Impact factor: 3.667

5.  Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2.

Authors:  Pallav D Patel; Pengrong Yan; Paul M Seidler; Hardik J Patel; Weilin Sun; Chenghua Yang; Nanette S Que; Tony Taldone; Paola Finotti; Ralph A Stephani; Daniel T Gewirth; Gabriela Chiosis
Journal:  Nat Chem Biol       Date:  2013-09-01       Impact factor: 15.040

6.  S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities.

Authors:  Antonio Martínez-Ruiz; Laura Villanueva; Cecilia González de Orduña; Daniel López-Ferrer; María Angeles Higueras; Carlos Tarín; Ignacio Rodríguez-Crespo; Jesús Vázquez; Santiago Lamas
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-03       Impact factor: 11.205

Review 7.  New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential.

Authors:  Yanyan Li; Tao Zhang; Steven J Schwartz; Duxin Sun
Journal:  Drug Resist Updat       Date:  2009 Feb-Apr       Impact factor: 18.500

8.  HSP90 inhibitor geldanamycin reverts IL-13- and IL-17-induced airway goblet cell metaplasia.

Authors:  Alejandro A Pezzulo; Rosarie A Tudas; Carley G Stewart; Luis G Vargas Buonfiglio; Brian D Lindsay; Peter J Taft; Nicholas D Gansemer; Joseph Zabner
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

9.  LPS induces pp60c-src-mediated tyrosine phosphorylation of Hsp90 in lung vascular endothelial cells and mouse lung.

Authors:  Nektarios Barabutis; Vaishali Handa; Christiana Dimitropoulou; Ruslan Rafikov; Connie Snead; Sanjiv Kumar; Atul Joshi; Gagan Thangjam; David Fulton; Stephen M Black; Vijay Patel; John D Catravas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-12       Impact factor: 5.464

Review 10.  Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.

Authors:  Alison Donnelly; Brian S J Blagg
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.